Add to ORKGLung cancer is one of the most common and lethal cancers all over the world (Malik et al., 2013). Non-small cell lung cancer (NSCLC) accounts for approximately 75 % of all cases of lung cancer (Minna et al., 2002)
<div><p>Objectives</p><p>Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentiall...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are potential prognostic m...
<div><p>Objectives</p><p>The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) a...
Lung cancer is the most common cancer worldwide with approximately 1.5 million newly diagnosed cases...
Objectives The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are po-tential ...
RPS6KB1 is the kinase of ribosomal protein S6 which is 70 kDa and is required for protein translatio...
IntroductionThe best hope of cure for patients with non-small cell lung cancer (NSCLC) is surgical r...
Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting prognostic ...
Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting prognostic ...
OBJECTIVES: Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting...
Aims: To determine the prognostic significance of pAkt expression in order to identify high-risk sta...
Lung cancer is the most common malignancy and the leading cause of cancer-related death in men and w...
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that functions as a key regulatory...
<div><p>Objectives</p><p>Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentiall...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are potential prognostic m...
<div><p>Objectives</p><p>The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) a...
Lung cancer is the most common cancer worldwide with approximately 1.5 million newly diagnosed cases...
Objectives The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are po-tential ...
RPS6KB1 is the kinase of ribosomal protein S6 which is 70 kDa and is required for protein translatio...
IntroductionThe best hope of cure for patients with non-small cell lung cancer (NSCLC) is surgical r...
Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting prognostic ...
Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting prognostic ...
OBJECTIVES: Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting...
Aims: To determine the prognostic significance of pAkt expression in order to identify high-risk sta...
Lung cancer is the most common malignancy and the leading cause of cancer-related death in men and w...
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that functions as a key regulatory...
<div><p>Objectives</p><p>Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentiall...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...